Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced new real-world preliminary data from the OPTION-VMS Phase IV, longitudinal, observational study, ...
(RNS) — The issue of women staffers who have the title of pastor in SBC churches has been up for debate repeatedly in recent years. DALLAS (RNS) — For the second year in a row, a move to bar churches ...
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback